Sentinel node procedure and endometrial cancer: Senti-endo results;Stratégie ganglionnaire et cancer de l'endomètre: Résultats de senti-endo

Bulletin du Cancer

Volumn 99, Issue 1, 2012, Pages 35-41

  Daraï, Émile ^a   Zacharopoulou, Chrysoula ^a   Touboul, Cyril ^a   Chéreau, Élisabeth ^a   Ballester, Marcos ^a  

^a HÔPITAL TENON   (France)

Author keywords

Endometrial cancer; Lymphadenectomy; Sentinel node procedure

Indexed keywords

ENDOMETRIUM CANCER; FALSE NEGATIVE RESULT; HUMAN; LYMPH NODE METASTASIS; PROCEDURES; REVIEW; SENTINEL LYMPH NODE; SENTINEL NODE PROCEDURE;

EID: 84856568163     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1511     Document Type: Article

References (36)

1. Belot A, Grosclaude P, Bossard N, et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008; 56 : 159-75.
2. Réseau Francim. Survie des patients atteints des cancers en France. Étude des registres de cancers de réseau Francim. Springer-Verlag ed., 2007.
3. Launoy G. Epidemiology of cancers in France. Rev Prat 2010; 60 : 178-82.
4. Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/ 1975-2006/, based on November 2008 SEER data submission, posted to the SEER web site 2009.
5. Gil-Moreno A, Díaz-Feijoo B, Morchón S, Xercavins J. Analysis of survival after laparoscopic-assisted vaginal hysterectomy compared with the conventional abdominal approach for early-stage endometrial carcinoma: a review of the literature. J Minim Invasive Gynecol 2006; 13 : 26-35. (Pubitemid 43129730)
6. Gemer O, Arie AB, Levy T, et al. Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study. Eur J Surg Oncol 2007; 33 : 644-7. (Pubitemid 46746533)
7. Arndt-Mierckel H, Martin A, Briese V, Fietkau R, Gerber B, Reimer T. Transection of vaginal cuff is an independent prognostic factor in stage I endometrial cancer. Eur J Surg Oncol 2008; 34 : 241-6.
8. Maggi R, Lissoni A, Spina F, et al. Adjuvant chemotherapy vs. radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 2006; 95 : 266-71. (Pubitemid 44187586)
9. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynaecol Obstet 2009; 105 : 103-4.
10. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 2005; 23 : 3668-75.
11. Havrilesky LJ, Cragun JM, Calingaert B, et al. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol 2005; 99 : 689-95. (Pubitemid 41686554)
12. Wong FC, Pang CP, Tang SK, et al. Treatment results of endometrial carcinoma with positive peritoneal washing, adnexal involvement and serosal involvement. Clin Oncol (R Coll Radiol) 2004; 16 : 350-5. (Pubitemid 38967256)
13. Fujimoto T, Nanjyo H, Fukuda J, et al. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence. Gynecol Oncol 2009; 112 : 342-7.
14. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100 : 1707-16.
15. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Lancet 2009 ; 373 : 125-36 (Epub 2008 Dec 16. Erratum in: Lancet 2009 ; 373 : 1764. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer [MRC ASTEC trial]: a randomised study).
16. Recommandations professionnelles : cancer de l'endomètre. Institut National du Cancer. www.e-cancer.fr.
17. Todo Y, Kato H, Minobe S, et al. Initial failure site according to primary treatment with or without para-aortic lymphadenectomy in endometrial cancer. Gynecol Oncol 2011; 121 : 314-8.
18. Todo Y, Kato H, Minobe S, et al. A validation study of the new revised FIGO staging system to estimate prognosis for patients with stage IIIC endometrial cancer. Gynecol Oncol 2011; 121 : 126-30.
19. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010; 375 : 1165-72.
20. Kwon JS, Mazgani M, Miller DM, et al. The significance of surgical staging in intermediate-risk endometrial cancer. Gynecol Oncol 2011; 122 : 50-4.
21. Ballester M, Koskas M, Coutant C, et al. Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy? BMC Cancer 2010; 10 : 465.
22. Frumovitz M, Singh DK, Meyer L, et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 2004; 95 : 463-8. (Pubitemid 39592505)
23. Selman TJ, Mann CH, Zamora J, Khan KS. A systematic review of tests for lymph node status in primary endometrial cancer. BMC Womens Health 2008; 5 : 8-17.
24. Fischerova D. Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors. Ultrasound Obstet Gynecol 2011; 38 : 246-66.
25. Suga T, Nakamoto Y, Saga T, et al. Clinical value of FDG-PET for preoperative evaluation of endometrial cancer. Ann Nucl Med 2011; 25 : 269-75.
26. Kitajima K, Suzuki K, Senda M, et al. Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone? Ann Nucl Med 2011; 25 : 511-9.
27. Ballester M, Dubernard G, Lécuru F, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 2011; 12 : 469-76.
28. May K, Bryant A, Dickinson HO, Kehoe S, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2010; 1 : CD007585.
29. Yabushita H, Shimazu M, Yamada H, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 2001; 80 : 139-44. (Pubitemid 32158450)
30. Bézu C, Coutant C, Ballester M, et al. Ultrastaging of lymph node in uterine cancers. J Exp Clin Cancer Res 2010; 29 : 5.
31. Kang S, Yoo HJ, Hwang JH, Lim MC, Seo SS, Park SY. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol 2011; 123 : 522-7.
32. Delpech Y, Coutant C, Darai E, Barranger E. Sentinel lymph node evaluation in endometrial cancer and the importance of micrometastases. Surg Oncol 2008; 17 : 237-45.
33. Goyal A, Newcombe RG, Chhabra A, Mansel RE, ALMANAC Trialists Group. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase. Breast Cancer Res Treat 2006; 99 : 203-8. (Pubitemid 44268268)
34. Delpech Y, Cortez A, Coutant C, et al. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol 2007; 18 : 1799-803. (Pubitemid 350111567)
35. Bats AS, Buénerd A, Querleu D, et al. Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study. Gynecol Oncol 2011; 123 : 230-5.
36. Coutant C, Barranger E, Cortez A, et al. Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer. Ann Oncol 2007; 18 : 1513-7. (Pubitemid 47365484)